Chai Discovery tests a new commercial route for AI-designed biologics through Lilly TuneLab
Explore how Chai Discovery and Lilly TuneLab are widening biotech access to AI miniprotein design and what must happen next.
Explore how Chai Discovery and Lilly TuneLab are widening biotech access to AI miniprotein design and what must happen next.
Eli Lilly partners with Chai Discovery to deploy AI for antibody drug design. Find out what this means for the future of biologics R&D.